James S. Scibetta, Director at Matinas BioPharma Holdings, Inc. (MTNB), bought 5,000 shares at $1.29 ($6K) on 2017-09-07, disclosed to the SEC on 2017-09-07.
Open-market purchase of $6k MTNB by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Clearly above the average filing.
| Filing → |
| PCRX | SELL | 2017-05-17 | $1.0M | — | Filing → |
| PCRX | SELL | 2017-01-19 | $1.5M | — | Filing → |
| PCRX | SELL | 2016-11-17 | $730K | — | Filing → |